GPC3 and hepatocellular carcinoma: Intravenous administration of GPC3-coupled lymphocytes (LC/GPC3+) resulted in the production of both anti-GPC3 antibodies and CTLS, reducing HCC growth and lysing HCC cells in culture (74).